Microwave ablation in treating intrahepatic recurrence of hepatocellular carcinoma after liver transplantation: An analysis of 11 cases

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87–108
   PubMed Web of Science ®Google Scholar
• Morise Z, Kawabe N, Tomishige H, Nagata H, Kawase J, Arakawa S, et al. Recent advances in the surgical treatment of hepatocellular carcinoma. World J Gastroenterol 2014;20:14381–92
   PubMed Web of Science ®Google Scholar
• Jonas S, Bechstein WO, Steinmüller T, Herrmann M, Radke C, Berg T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001;33:1080–6
   PubMed Web of Science ®Google Scholar
• Rubin J, Ayoub N, Kaldas F, Saab S. Management of recurrent hepatocellular carcinoma in liver transplant recipients: A systematic review. Exp Clin Transplant 2012;10:531–43
   PubMed Web of Science ®Google Scholar
• Zhou B, Shan H, Zhu KS, Jiang ZB, Guan SH, Meng XC, et al. Chemoembolization with lobaplatin mixed with iodized oil for unresectable recurrent hepatocellular carcinoma after orthotopic liver transplantation. J Vasc Interv Radiol 2010;21:333–8
   PubMed Web of Science ®Google Scholar
• Liang P, Wang Y. Microwave ablation of hepatocellular carcinoma. Oncology 2007;72:124–31
   PubMed Web of Science ®Google Scholar
• Wang Y, Liang P, Yu X, Cheng Z, Yu J. Ultrasound-guided percutaneous microwave ablation of adrenal metastasis: Preliminary results. Int J Hyperthermia 2009;25:455–61
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. Image-guided tumor ablation: Standardization of terminology and reporting criteria – a 10-year update. Radiology 2014;25:1691–705
   Web of Science ®Google Scholar
• Liu S, Liang P, Yu X, Cheng Z, Han Z, Yu J. Percutaneous microwave ablation for liver tumours adjacent to the marginal angle. Int J Hyperthermia 2014;30:306–11
   PubMed Web of Science ®Google Scholar
• Huang H, Liang P, Yu X, Cheng Z, Han Z, Yu J. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder. Int J Hyperthermia 2015;31:40–7
   PubMed Web of Science ®Google Scholar
• Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2008;47:82–9
   PubMed Web of Science ®Google Scholar
• Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693–9
   PubMed Web of Science ®Google Scholar
• Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: A retrospective, exploratory analysis. Lancet Oncol 2009;10:35–43
   PubMed Web of Science ®Google Scholar
• Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S, et al. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome. Cancer 2000;88:538–43
   PubMed Web of Science ®Google Scholar
• Zheng SS, Xu X, Wu J, Chen J, Wang WL, Zhang M, et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 2008;85:1726–32
   PubMed Web of Science ®Google Scholar
• Regalia E, Coppa J, Pulvirenti A, Romito R, Schiavo M, Burgoa L, et al. Liver transplantation for small hepatocellular carcinoma in cirrhosis: Analysis of our experience. Trampl Proc 2001;33:1442
   PubMed Web of Science ®Google Scholar
• Little SA, Fong Y. Hepatocellular carcinoma: Current surgical management. Semin Oncol 2001;28:474
   PubMed Web of Science ®Google Scholar
• Sposito C, Mariani L, Germini A, Flores Reyes M, Bongini M, Grossi G, et al. Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: A case-control study. J Hepatol 2013;59:59–66
   PubMed Web of Science ®Google Scholar
• Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee FT Jr. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology 2005;236:132–9
   PubMed Web of Science ®Google Scholar
• Huang S, Yu J, Liang P, Yu X, Cheng Z, Han Z, et al. Percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: A long-term follow-up. Eur J Radiol 2014;83:552–8
   PubMed Web of Science ®Google Scholar
• Liang P, Yang W, Yu X, Dong B. Malignant liver tumors: Treatment with percutaneous microwave ablation – complications among cohort of 1136 patients. Radiology 2009;251:933–40
   PubMed Web of Science ®Google Scholar
• Chan AC, Poon RT, Cheung TT, Chok KS, Chan SC, Fan ST, et al. Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. World J Surg 2012;36:151–6
   PubMed Web of Science ®Google Scholar
• Liang P, Yu J, Yu X, Wang X, Wei Q, Yu S, et al. Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: A multicentre analysis of 1363 treatment-naive lesions in 1007 patients in China. Gut 2012;61:1100–1
   PubMed Web of Science ®Google Scholar
• Hollebecque A, Decaens T, Boleslawski E, Mathurin P, Duvoux C, Pruvot FR, et al. Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation. Gastroenterol Clin Biol 2009;33:361–9
   PubMed Web of Science ®Google Scholar
• Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier A, et al. Recommendations for liver transplantation for hepatocellular carcinoma: An international consensus conference report. Lancet Oncol 2012;13:e11–22
   PubMed Web of Science ®Google Scholar
• Mancuso A, Mazzola A, Cabibbo G, Perricone G, Enea M, Galvano A, et al. Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis. Dig Liver Dis 2015;47:324–30
   PubMedGoogle Scholar
• Dharancy S, Romano O, Lohro R, Pageaux GP, De Ledighen V, Hurtova M, et al. Tolerability of sorafenib in recurrent hepatocellular carcinoma after liver transplantation: A case-control study. Liver Transpl 2008;14(S1):S216
   Web of Science ®Google Scholar
• Ho CK, Chapman WC, Brown DB. Radiofrequency ablation of recurrent hepatocellular carcinoma in a patient after liver transplantation: Two-year follow-up. J Vasc Interv Radiol 2007;18:1451–3
   PubMed Web of Science ®Google Scholar
• Gringeri E, Boetto R, Bassi D, D’Amico FE, Polacco M, Romano M, et al. Laparoscopic microwave thermal ablation for late recurrence of local hepatocellular carcinoma after liver transplant: Case report. Prog Transplant 2014;24:142–5
   PubMed Web of Science ®Google Scholar
• Wojcicki M, Milkiewicz P, Silva M. Biliary tract complications after liver transplantation: A review. Dig Surg 2008;25:245–57
   PubMed Web of Science ®Google Scholar